Literature DB >> 18590929

The effect of surface demineralization of cortical bone allograft on the properties of recombinant adeno-associated virus coatings.

Cemal Yazici1, Laura Yanoso, Chao Xie, David G Reynolds, R Jude Samulski, Jade Samulski, Judith Yannariello-Brown, Arthur A Gertzman, Xinping Zhang, Hani A Awad, Edward M Schwarz.   

Abstract

Freeze-dried recombinant adeno-associated virus (rAAV) coated structural allografts have emerged as an approach to engender necrotic cortical bone with host factors that will persist for weeks following surgery to facilitate revascularization, osteointegration, and remodeling. However, one major limitation is the nonporous cortical surface that prohibits uniform distribution of the rAAV coating prior to freeze-drying. To overcome this we have developed a demineralization method to increase surface absorbance while retaining the structural integrity of the allograft. Demineralized bone wafers (DBW) made from human femoral allograft rings demonstrated a significant 21.1% (73.6+/-3.9% versus 52.5+/-2.6%; p<0.001) increase in percent surface area coating versus mineralized controls. Co-incubation of rAAV-luciferase (rAAV-Luc) coated DBW with a monolayer of C3H10T1/2 cells in culture led to peak luciferase levels that were not significantly different from soluble rAAV-Luc controls (p>0.05), although the peaks occurred at 60h and 12h, respectively. To assess the transduction efficiency of rAAV-Luc coated DBW in vivo, we first performed a dose response with allografts containing 10(7), 10(9) or 10(10) particles that were surgically implanted into the quadriceps of mice, and assayed by in vivo bioluminescence imaging (BLI) on days 1, 3, 5, 7, 10, 14, and 21. The results demonstrated a dose response in which the DBW coated with 10(10) rAAV-Luc particles achieved peak gene expression levels on day 3, which persisted until day 21, and was significantly greater than the 10(7) dose throughout this time period (p<0.01). A direct comparison of mineralized versus DBW coated with 10(10) rAAV-Luc particles failed to demonstrate any significant differences in transduction kinetics or efficiency in vivo. Thus, surface demineralization of human cortical bone allograft increases its absorbance for uniform rAAV coating, without affecting vector transduction efficiency.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18590929      PMCID: PMC2570090          DOI: 10.1016/j.biomaterials.2008.06.007

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  40 in total

1.  Factors affecting nonunion of the allograft-host junction.

Authors:  F J Hornicek; M C Gebhardt; W W Tomford; J I Sorger; M Zavatta; J P Menzner; H J Mankin
Journal:  Clin Orthop Relat Res       Date:  2001-01       Impact factor: 4.176

Review 2.  Gene therapy for the treatment of musculoskeletal diseases.

Authors:  Christopher H Evans; Steven C Ghivizzani; James H Herndon; Paul D Robbins
Journal:  J Am Acad Orthop Surg       Date:  2005 Jul-Aug       Impact factor: 3.020

3.  The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: a preliminary report.

Authors:  S D Boden; T A Zdeblick; H S Sandhu; S E Heim
Journal:  Spine (Phila Pa 1976)       Date:  2000-02-01       Impact factor: 3.468

4.  Remodeling of cortical bone allografts mediated by adherent rAAV-RANKL and VEGF gene therapy.

Authors:  Hiromu Ito; Mette Koefoed; Prarop Tiyapatanaputi; Kirill Gromov; J Jeffrey Goater; Jonathan Carmouche; Xinping Zhang; Paul T Rubery; Joseph Rabinowitz; R Jude Samulski; Takashi Nakamura; Kjeld Soballe; Regis J O'Keefe; Brendan F Boyce; Edward M Schwarz
Journal:  Nat Med       Date:  2005-02-13       Impact factor: 53.440

5.  Biological effects of rAAV-caAlk2 coating on structural allograft healing.

Authors:  Mette Koefoed; Hiromu Ito; Kirill Gromov; David G Reynolds; Hani A Awad; Paul T Rubery; Michael Ulrich-Vinther; Kjeld Soballe; Robert E Guldberg; Angela S P Lin; Regis J O'Keefe; Xinping Zhang; Edward M Schwarz
Journal:  Mol Ther       Date:  2005-08       Impact factor: 11.454

6.  Efficacy of etanercept for wear debris-induced osteolysis.

Authors:  L M Childs; J J Goater; R J O'Keefe; E M Schwarz
Journal:  J Bone Miner Res       Date:  2001-02       Impact factor: 6.741

7.  Use of rhBMP-2 in combination with structural cortical allografts: clinical and radiographic outcomes in anterior lumbar spinal surgery.

Authors:  J Kenneth Burkus; Harvinder S Sandhu; Matthew F Gornet; Michael C Longley
Journal:  J Bone Joint Surg Am       Date:  2005-06       Impact factor: 5.284

8.  Biodegradable foam coating of cortical allografts.

Authors:  S Bondre; K U Lewandrowski; V Hasirci; M V Cattaneo; J D Gresser; D L Wise; W W Tomford; D J Trantolo
Journal:  Tissue Eng       Date:  2000-06

9.  Incidence of infection with the use of non-irradiated morcellised allograft bone washed at the time of revision arthroplasty of the hip.

Authors:  F N K Kwong; T Ibrahim; R A Power
Journal:  J Bone Joint Surg Br       Date:  2005-11

10.  Freeze-dried tendon allografts as tissue-engineering scaffolds for Gdf5 gene delivery.

Authors:  Patrick Basile; Tulin Dadali; Justin Jacobson; Sys Hasslund; Michael Ulrich-Vinther; Kjeld Søballe; Yasuhiko Nishio; M Hicham Drissi; Howard N Langstein; David J Mitten; Regis J O'Keefe; Edward M Schwarz; Hani A Awad
Journal:  Mol Ther       Date:  2008-01-08       Impact factor: 11.454

View more
  8 in total

Review 1.  Direct gene therapy for bone regeneration: gene delivery, animal models, and outcome measures.

Authors:  Gadi Pelled; Ayelet Ben-Arav; Colleen Hock; David G Reynolds; Cemal Yazici; Yoram Zilberman; Zulma Gazit; Hani Awad; Dan Gazit; Edward M Schwarz
Journal:  Tissue Eng Part B Rev       Date:  2010-02       Impact factor: 6.389

Review 2.  Gene therapy approaches to regenerating bone.

Authors:  Nadav Kimelman Bleich; Ilan Kallai; Jay R Lieberman; Edward M Schwarz; Gadi Pelled; Dan Gazit
Journal:  Adv Drug Deliv Rev       Date:  2012-03-10       Impact factor: 15.470

3.  The enhancement of bone allograft incorporation by the local delivery of the sphingosine 1-phosphate receptor targeted drug FTY720.

Authors:  Caren E Petrie Aronin; Soo J Shin; Kimberly B Naden; Peter D Rios; Lauren S Sefcik; Sarah R Zawodny; Namory D Bagayoko; Quanjun Cui; Yusuf Khan; Edward A Botchwey
Journal:  Biomaterials       Date:  2010-09       Impact factor: 12.479

4.  Self-complementary AAV2.5-BMP2-coated femoral allografts mediated superior bone healing versus live autografts in mice with equivalent biomechanics to unfractured femur.

Authors:  Cemal Yazici; Masahiko Takahata; David G Reynolds; Chao Xie; R Jude Samulski; Jade Samulski; E Jeffrey Beecham; Arthur A Gertzman; Mark Spilker; Xinping Zhang; Regis J O'Keefe; Hani A Awad; Edward M Schwarz
Journal:  Mol Ther       Date:  2011-01-04       Impact factor: 11.454

Review 5.  Recent tissue engineering-based advances for effective rAAV-mediated gene transfer in the musculoskeletal system.

Authors:  Ana Rey-Rico; Magali Cucchiarini
Journal:  Bioengineered       Date:  2016-04       Impact factor: 3.269

6.  Enhanced bone formation in large segmental radial defects by combining adipose-derived stem cells expressing bone morphogenetic protein 2 with nHA/RHLC/PLA scaffold.

Authors:  Wei Hao; Jinlei Dong; Ming Jiang; Junwei Wu; Fuzhai Cui; Dongsheng Zhou
Journal:  Int Orthop       Date:  2010-02-07       Impact factor: 3.075

7.  Synthetic scaffold coating with adeno-associated virus encoding BMP2 to promote endogenous bone repair.

Authors:  Kenneth M Dupont; Joel D Boerckel; Hazel Y Stevens; Tamim Diab; Yash M Kolambkar; Masahiko Takahata; Edward M Schwarz; Robert E Guldberg
Journal:  Cell Tissue Res       Date:  2011-06-22       Impact factor: 5.249

Review 8.  Musculoskeletal molecular imaging: a comprehensive overview.

Authors:  Marie K Reumann; Mitchell C Weiser; Philipp Mayer-Kuckuk
Journal:  Trends Biotechnol       Date:  2010-01-04       Impact factor: 19.536

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.